Sex differences in depressive response during monoamine depletions in remitted depressive subjects

Journal of Clinical Psychiatry

Volumn 67, Issue 10, 2006, Pages 1618-1623

  Moreno, Francisco A ^a   McGahuey, Cynthia A ^a   Freeman, Marlene P ^a   Delgado, Pedro L ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; MONOAMINE; TRYPTOPHAN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; REMISSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; STUDENT T TEST;

EID: 33751225355     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n1019     Document Type: Article

References (34)

1. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111
2. Weissman MM, Bland R, Joyce PR, et al. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993;29:77-84
3. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949-958
4. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey, 1 : lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:77-84
5. Simpson HB, Nee JC, Endicott J. First episode major depression: few differences in course. Arch Gen Psychiatry 1997;54:633-639
6. Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997;58(suppl 15):12-18
7. Hildebrandt MG, Stage KB, Kragh-Soerensen P. Gender differences in severity, symptomatology and distribution of melancholia in major depression. Psychopathology 2003;36:204-212
8. Leibenluft E. Gender Differences in Mood and Anxiety Disorders: From Bench to Bedside: Annual Review of Psychiatry. Washington, DC: American Psychiatric Association Press; 1999
9. Wilson IC, Rabon AM, Buffaloe WL. Imipramine therapy in depressive syndromes: prediction of therapeutic outcome. Psychosomatics 1967;8: 203-207
10. Raskin A. Age-sex differences in response to antidepressant drugs. J Nerv Ment Dis 1974;159:120-130
11. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-1452
12. Martenyi F, Dossenbach M, Mraz K, et al. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur Neuropsychopharmacol 2001;11: 227-232
13. Quitkin FM, Stewart JW, McGrath PJ, et al. Are there differences between women's and men's antidepressant responses? Am J Psychiatry 2002;159:1848-1854
14. Pinto-Meza A, Usall J, Serrano-Blanco A, et al. Gender differences in response to antidepressant treatment prescribed in primary care: does menopause make a difference? J Affect Disord 2006;93:53-60
15. Thase ME, Entsuah R, Cantillon M, et al. Relative antidepressant efficacy in venlafaxine and SSRIs: sex-age interactions. J Womens Health (Larchmt) 2005;14:609-616
16. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 1997;94:5308-5313
17. Ellenbogen MA, Young SN, Dean P, et al. Mood response to tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology 1996;15:465-474
18. Booij L, Van Der Does W, Benkelfat C, et al. Predictors of mood response to acute tryptophan depletion: a reanalysis. Neuropsychopharmacology 2002;27:852-861
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
20. First MB, Gibbon M, Spitzer RL, et al. User's Guide for the Structured Interview for DSM-IV Axis I Disorders-Research Version (SCID-I, version 2.0, February 1996 final version). New York, NY: Biometric Research, New York State Psychiatric Institute; 1996
21. Mazure CM, Nelson JC, Price LH. Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry 1986;43:451-456
22. Young SN, Smith SE, Pihl R, et al. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 1985;87:173-177
23. Moreno FA, Gelenberg AJ, Heninger GR, et al. Tryptophan depletion and depressive vulnerability. Biol Psychiatry 1999;46:498-505
24. Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action: reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-418
25. Woods SW, Charney DS, Goodman WK, et al. Carbon dioxide induced anxiety. Arch Gen Psychiatry 1988;45:43-52
26. Norusis MJ. SPSS Base System User's Guide. Chicago, Ill: SPSS Inc; 1998
27. Jones MD, Lucki I. Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice. Neuropsychopharmacology 2005;30:1039-1047
28. Smith KA, Morris JS, Friston KJ, et al. Brain mechanisms associated with depressive relapse and associated with cognitive impairment following acute tryptophan depletion. Br J Psychiatry 1999;174:525-529
29. Bremner JD, Vythilingam M, Ng CK. Regional brain metabolic corre-lates of α-methylparatyrosine-induced depressive symptoms: implications for the neuronal circuitry of depression. JAMA 2003;289:3125-3134
30. Neumeister A, Nugent AC, Waldeck T, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 2004;61: 765-773
31. McEwen BS, Alves SE, Bulloch K, et al. Clinically relevant basic science studies of gender differences and sex hormone effects. Psychopharmacol Bull 1998;34:251-259
32. Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996;153:974-984
33. Kendall DA, Stancel GM, Enna SJ. Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 1981; 211:1183-1185
34. Schmidt PJ, Rubinow DR. Menopause-related affective disorders: a justification for further study. Am J Psychiatry 1991;148:844-852